UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039858
Receipt number R000045076
Scientific Title Research and development of innovative method to diagnose pelvic floor dysfunction
Date of disclosure of the study information 2020/03/18
Last modified on 2021/03/21 15:15:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research and development of innovative method to diagnose pelvic floor dysfunction

Acronym

Research and development of innovative method to diagnose pelvic floor dysfunction

Scientific Title

Research and development of innovative method to diagnose pelvic floor dysfunction

Scientific Title:Acronym

Research and development of innovative method to diagnose pelvic floor dysfunction

Region

Japan


Condition

Condition

Pelvic floor dysfunction

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop a new diagnostic technique for accurate diagnosis of pelvic floor dysfunction, the shape of the vaginal cavity and the compliance of vagina is investigated and analyzed in patients with pelvic organ prolapse and normal patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intravaginal pressure and volume

Key secondary outcomes

Shape of vagina
Tissue compliance measured by elastgraphy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

The vaginal cavity is ultrasonically constructed to measure vaginal wall compliance, by using intravaginal balloon dilation.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) Patients who visited a gynecological outpatient clinic.
2) Patients whose performance Status is 0-1 can be examined at the obstetrics and gynecology examination table.
3) The consent has been obtained from the person in writing.

Key exclusion criteria

1) Patients whose vaginal cavity is too small to allow internal examination and transvaginal ultrasonography.
2) Patients who cannot undergo internal examination and transvaginal ultrasonography due to pain.
3) Patients with infections in gynecological organs
4) Other patients who are judged by the investigator or participating physician to be ineligible for this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name Kimura

Organization

Osaka University Graduate School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

565-0871

Address

2-2 Yamadaoka Suita

TEL

0668793351

Email

tadashi@gyne.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Michiko
Middle name
Last name Kodama

Organization

Osaka University Graduate School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

565-0871

Address

2-2 Yamadaoka Suita

TEL

0668793351

Homepage URL


Email

mkodama@gyne.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Osaka University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University

Address

2-2 Yamadaoka Zuita

Tel

0662108296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 18 Day

Date of IRB

2020 Year 03 Month 18 Day

Anticipated trial start date

2020 Year 04 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 18 Day

Last modified on

2021 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045076


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name